Mount Sinai PRIME

Lake Success, New York 11041

0 studies enrolling now · 4 studies all time

What they study most

Allogeneic Hematopoietic Stem Cell Transplantation, Carcinoma, Ovarian Epithelial, Colitis, Ulcerative, Fallopian Tube Adenocarcinoma, Fallopian Tube Neoplasms, Fallopian Tube Serous Adenocarcinoma, Hypertension, Ovarian Cancer, Ovarian Neoplasms, Ovarian Serous Adenocarcinoma, Peritoneal Cancer, Peritoneal Carcinoma

Studies at this site

• Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery — Running, not enrolling
• An Efficacy and Safety Study in Children 6 to Less Than 18 Years of Age With Hypertension — Completed
• An Efficacy and Safety Study of Vedolizumab Intravenous (IV) Compared to Adalimumab Subcutaneous (SC) in Participants With Ulcerative Colitis — Completed
• A Dose-Finding Study of Vedolizumab for Treatment of Steroid-Refractory Acute Intestinal Graft-Versus-Host Disease (GvHD) in Participants Who Have Undergone Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HSCT) — Stopped early